Article
Pyrosequencing Assay for BRCA1 Methylation Analysis: Results from a Cross-Validation Study.
The Journal of molecular diagnostics : JMD - 1 Apr 2023
Sahnane Nora, Rivera Daniela, Libera Laura, Carnevali Ileana, Banelli Barbara, Facchi Sofia, Gismondi Viviana, Paudice Michele, Cirmena Gabriella, Vellone Valerio G, Sessa Fausto, Varesco Liliana, Tibiletti Maria G
Abstract excerpt
Epithelial ovarian cancers (EOCs) harboring germline or somatic pathogenic variants in BRCA1 and BRCA2 genes show sensitivity to poly(ADP-ribose) polymerase inhibition. It has been suggested that BRCA1 promoter methylation is perhaps a better determinant of therapy response, because of its intrinsic dynamic feature, with respect to genomic scars or gene mutation. Conflicting evidence was reported so far, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
